Open source fraction collector/MALDI spotter for proteomics
- PMID: 35518277
- PMCID: PMC9062586
- DOI: 10.1016/j.ohx.2022.e00305
Open source fraction collector/MALDI spotter for proteomics
Abstract
We describe a complete open-source hardware/software solution for high performance thermostatted peptide fraction collection to support mass spectrometry experiments with complex proteomes. The instrument is easy to assemble using parts readily available through retail channels at a fraction of the cost compared to typical commercial systems. Control software is written in Python allowing for rapid customization. We demonstrate several useful applications, including the automated deposition of LC separated peptides for matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) as well as collection and concatenation of peptide fractions from nanoflow HPLC separations.
Keywords: Fraction collection; HPLC, high pressure liquid chromatography; LC, liquid chromatography; LC-MALDI; LC-MS, Liquid Chromatography/Mass spectrometry; MALDI-MS, matrix-assisted laser desorption ionization mass spectrometry; MS, mass spectrometer/mass spectrometry; OEM, Original Equipment Manufacturer; Open source; Proteomics; Python.
© 2022 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Washburn M.P., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001;19(3):242–247. - PubMed
-
- Zhou F., Sikorski T.W., Ficarro S.B., Webber J.T., Marto J.A. Online nanoflow reversed phase-strong anion exchange-reversed phase liquid chromatography-tandem mass spectrometry platform for efficient and in-depth proteome sequence analysis of complex organisms. Anal. Chem. 2011;83(18):6996–7005. - PMC - PubMed
-
- Brown F.C., Still E., Koche R.P., Yim C.Y., Takao S., Cifani P., Reed C., Gunasekera S., Ficarro S.B., Romanienko P., Mark W., McCarthy C., de Stanchina E., Gonen M., Seshan V., Bhola P., O'Donnell C., Spitzer B., Stutzke C., Lavallee V.P., Hebert J., Krivtsov A.V., Melnick A., Paietta E.M., Tallman M.S., Letai A., Sauvageau G., Pouliot G., Levine R., Marto J.A., Armstrong S.A., Kentsis A. MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia. Cancer Discov. 2018;8:478–497. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
